Donald Rogers Reynolds - Net Worth and Insider Trading

Donald Rogers Reynolds Net Worth

The estimated net worth of Donald Rogers Reynolds is at least $1,182 dollars as of 2024-05-06. Donald Rogers Reynolds is the Director of Oncotelic Therapeutics Inc and owns about 30,000 shares of Oncotelic Therapeutics Inc (OTLC) stock worth over $1,182. Details can be seen in Donald Rogers Reynolds's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Donald Rogers Reynolds has not made any transactions after 2016-12-16 and currently still holds the listed stock(s).

Transaction Summary of Donald Rogers Reynolds

To

Donald Rogers Reynolds Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Donald Rogers Reynolds owns 1 companies in total, including Oncotelic Therapeutics Inc (OTLC) .

Click here to see the complete history of Donald Rogers Reynolds’s form 4 insider trades.

Insider Ownership Summary of Donald Rogers Reynolds

Ticker Comapny Transaction Date Type of Owner
OTLC Oncotelic Therapeutics Inc 2016-12-16 director

Donald Rogers Reynolds Latest Holdings Summary

Donald Rogers Reynolds currently owns a total of 1 stock. Donald Rogers Reynolds owns 30,000 shares of Oncotelic Therapeutics Inc (OTLC) as of December 16, 2016, with a value of $1,182.

Latest Holdings of Donald Rogers Reynolds

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OTLC Oncotelic Therapeutics Inc 2016-12-16 30,000 0.04 1,182

Holding Weightings of Donald Rogers Reynolds


Donald Rogers Reynolds Form 4 Trading Tracker

According to the SEC Form 4 filings, Donald Rogers Reynolds has made a total of 0 transactions in Oncotelic Therapeutics Inc (OTLC) over the past 5 years. The most-recent trade in Oncotelic Therapeutics Inc is the acquisition of 30,000 shares on December 16, 2016, which cost Donald Rogers Reynolds around $10,500.

Insider Trading History of Donald Rogers Reynolds

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Donald Rogers Reynolds Trading Performance

GuruFocus tracks the stock performance after each of Donald Rogers Reynolds's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Donald Rogers Reynolds is 91.43%. GuruFocus also compares Donald Rogers Reynolds's trading performance to market benchmark return within the same time period. The performance of stocks bought by Donald Rogers Reynolds within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Donald Rogers Reynolds's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Donald Rogers Reynolds

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.71
Relative Return to S&P 500(%) 4.98

Donald Rogers Reynolds Ownership Network

Ownership Network List of Donald Rogers Reynolds

No Data

Ownership Network Relation of Donald Rogers Reynolds


Donald Rogers Reynolds Owned Company Details

What does Oncotelic Therapeutics Inc do?

Who are the key executives at Oncotelic Therapeutics Inc?

Donald Rogers Reynolds is the director of Oncotelic Therapeutics Inc. Other key executives at Oncotelic Therapeutics Inc include CHIEF EXECUTIVE OFFICER Vuong Trieu , CHIEF BUSINESS OFFICER Saran Saund , and CHIEF FINANCIAL OFFICER Amit B. Shah .

Oncotelic Therapeutics Inc (OTLC) Insider Trades Summary

Over the past 18 months, Donald Rogers Reynolds made no insider transaction in Oncotelic Therapeutics Inc (OTLC). Other recent insider transactions involving Oncotelic Therapeutics Inc (OTLC) include a net purchase of 1,016,888 shares made by Vuong Trieu ,

In summary, during the past 3 months, insiders sold 0 shares of Oncotelic Therapeutics Inc (OTLC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncotelic Therapeutics Inc (OTLC) were sold and 1,016,888 shares were bought by its insiders, resulting in a net purchase of 1,016,888 shares.

Oncotelic Therapeutics Inc (OTLC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oncotelic Therapeutics Inc Insider Transactions

No Available Data

Donald Rogers Reynolds Mailing Address

Above is the net worth, insider trading, and ownership report for Donald Rogers Reynolds. You might contact Donald Rogers Reynolds via mailing address: C/o Wyrick Robbins Yates & Ponton Llp, 4101 Lake Boone Trail, Suite 300, Raleigh Nc 27607.

Discussions on Donald Rogers Reynolds

No discussions yet.